Updates on emerging research on the role of epigenetics in the etiology of autism. From the 2013 ARI Think Tank.
Published 04/27/2013
Dr. James is a Research Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences and the Director of the Autism Metabolic Genomics Laboratory at the Arkansas Children’ Hospital Research Institute. She received her undergraduate degree from Mills College in Oakland CA and her PhD in Nutritional Biochemistry from UCLA. Dr. James has 25 years research experience and is nationally and internationally recognized as an expert on folate and glutathione metabolism. Dr. James has published over 140 peer-reviewed papers and has received the American Society for Nutritional Sciences award for innovative research contributing to the understanding of human nutrition and disease. She is also the co-director of ARI’s Scientific Advisory Board.
Biomarkers start telling us a story: Autism pathophysiology revisited
Learn about emerging research on biomarkers and autism from a recent ARI Research Grant recipient. This is a joint presentation with the World Autism Organisation. The presentation by Dr.
The Low-Hanging Fruit: Exploring Monogenic Syndromes with Elevated Rates of Autism
Learn research updates on how genes associated with autism are functioning in the brain and how changes in these genes are linked to characteristics of autism and other conditions.
Prenatal exposure to cannabis may increase likelihood of autism
Cannabis use during pregnancy may alter placental and fetal DNA methylation (the process of turning genes “on” and “off”) in ways that increase the likelihood of autism spectrum disorder (ASD) or other
Behavioral and Brain Signatures of Autism in Females
Kaustubh Supekar, Ph.D., examines recent findings about gender/sex differences in autism phenotypes and brain organization. He highlights the underrepresentation of females in autism and underscores the need for a large-scale science approach. The
Alzheimer’s drug appears to benefit adult men with fragile X
A drug intended to help people with Alzheimer’s disease may also be beneficial for individuals with fragile X syndrome, according to a new study. Fragile X syndrome is the most common known
“Genetic wrinkles” in DNA may explain some cases of ASD
Researchers in Canada report that expanded tandem DNA repeats—what they dub “genetic wrinkles” in DNA—may play a significant role in autism spectrum disorders (ASD). Stephen Scherer and his team, including first author